By Richard E. Greene, MD
Peer Reviewed
In July of 2012, the FDA approved the use of Tenofovir-Emtricitabine (Truvada, a single blue pill) daily as Pre-Exposure Prophylaxis (PrEP) …
By Richard E. Greene, MD
Peer Reviewed
In July of 2012, the FDA approved the use of Tenofovir-Emtricitabine (Truvada, a single blue pill) daily as Pre-Exposure Prophylaxis (PrEP) …
Please enjoy this post from the archives dated September 30, 2011
By Vicky Jones, MD
A 40-year-old female presented to her primary care provider with a chief complaint of weight gain over the past year. She wants to be fully evaluated for any kind …
By Jonathan Gursky
Peer Reviewed
Approximately 5.2 million Americans are currently living with Alzheimer’s disease (AD) [1], with this number expected to triple by the year 2050 [2]. Alzheimer’s disease is …
By Mark Adelman, MD
Peer Reviewed
The Centers for Disease Control and Prevention CDC confirmed on May 12 that a second case of Middle East Respiratory …
By Nancy Hernandez
I did not know you until that time,
We scurried into your room
And found you pulseless, breathless, lifeless.
I was asked to keep
Time.
Fumbling for paper, I resorted to …
Welcome to HotSpots. In this series, we highlight unique websites of interest to the medical profession. Feel free to make suggestions for sites that should be featured in this series by clicking the comment field or sending us an email.
Matthew …
By Molly Anderson
Peer Reviewed
Managing hyperlipidemia is a mainstay of cardiovascular risk reduction. The 2013 ACC/AHA guidelines no longer target specific low-density lipoprotein (LDL)-cholesterol levels, but recommend lipid-lowering therapies of varying …
By Kaley Myer, MD
Peer Reviewed
The US government has offered to assist the Nigerian government this week in an effort to locate hundreds of girls kidnapped from …